MX2007007614A - Agente preventivo o terapeutico para glaucoma. - Google Patents

Agente preventivo o terapeutico para glaucoma.

Info

Publication number
MX2007007614A
MX2007007614A MX2007007614A MX2007007614A MX2007007614A MX 2007007614 A MX2007007614 A MX 2007007614A MX 2007007614 A MX2007007614 A MX 2007007614A MX 2007007614 A MX2007007614 A MX 2007007614A MX 2007007614 A MX2007007614 A MX 2007007614A
Authority
MX
Mexico
Prior art keywords
preventive
therapeutic agent
glaucoma
intraocular pressure
salt
Prior art date
Application number
MX2007007614A
Other languages
English (en)
Inventor
Shin Sugimoto
Ken Mizuno
Masatoshi Takahashi
Makoto Kanebako
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of MX2007007614A publication Critical patent/MX2007007614A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un agente preventivo o terapeutico para glaucoma que tiene fuerte potencia de disminucion de presion intraocular, que exhibe actividad de disminucion de presion intraocular satisfactoria aun de la presion intraocular normal; se provee un agente preventivo o terapeutico para glaucoma, o agente preventivo o terapeutico para hipertension ocular, o gotas para ojos relevantes, que comprenden homopiperazina de (S)-(-)-1-(4-fluoro-5-isoquinolina sulfonil)-2-metilo o su sal y acido fosforico o su sal.
MX2007007614A 2004-12-23 2005-12-22 Agente preventivo o terapeutico para glaucoma. MX2007007614A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63811804P 2004-12-23 2004-12-23
PCT/JP2005/023570 WO2006068208A1 (ja) 2004-12-23 2005-12-22 緑内障予防又は治療剤

Publications (1)

Publication Number Publication Date
MX2007007614A true MX2007007614A (es) 2007-08-15

Family

ID=36601805

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007614A MX2007007614A (es) 2004-12-23 2005-12-22 Agente preventivo o terapeutico para glaucoma.

Country Status (24)

Country Link
EP (1) EP1818059B1 (es)
JP (1) JP4099201B2 (es)
KR (1) KR101286813B1 (es)
CN (1) CN101087613B (es)
AT (1) ATE415972T1 (es)
AU (1) AU2005320085B2 (es)
BR (1) BRPI0519007A2 (es)
CA (1) CA2585372A1 (es)
CY (1) CY1108651T1 (es)
DE (1) DE602005011476D1 (es)
DK (1) DK1818059T3 (es)
EA (1) EA011085B1 (es)
ES (1) ES2317338T3 (es)
HK (1) HK1113312A1 (es)
MX (1) MX2007007614A (es)
MY (1) MY138811A (es)
NO (1) NO20072187L (es)
NZ (1) NZ555137A (es)
PL (1) PL1818059T3 (es)
PT (1) PT1818059E (es)
SI (1) SI1818059T1 (es)
TW (1) TWI367098B (es)
WO (1) WO2006068208A1 (es)
ZA (1) ZA200704874B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090079689A1 (en) * 2005-07-14 2009-03-26 Akio Miyata Display Device And Electric Apparatus Using The Same
CN102099037A (zh) 2008-07-25 2011-06-15 旭化成制药株式会社 含有磺酰胺化合物的稳定的水溶液组合物
TW201235040A (en) * 2011-02-04 2012-09-01 Kowa Co Drug therapy for preventing or treating glaucoma
EA026904B1 (ru) * 2012-11-23 2017-05-31 Игорь Михайлович Юхт Способ количественного определения полигексаметиленбигуанидина (пгмб) гидрохлорида в составах для приготовления жидких лекарственных средств для лечения заболеваний глаз и носа (2 варианта)
EP2990040B1 (en) * 2013-04-24 2019-12-04 Kyushu University, National University Corporation Therapeutic agent for eyeground disease
CA2962624C (en) * 2014-09-25 2022-08-30 Kowa Company, Ltd. Pharmaceutical preparation comprising ripasudil and a polyolefin-based resin
HUE048790T2 (hu) * 2014-09-25 2020-09-28 Kowa Co Vizes készítmény
JP5951920B1 (ja) 2014-12-12 2016-07-13 興和株式会社 新規水性組成物
TWI699205B (zh) * 2014-12-12 2020-07-21 日商興和股份有限公司 用於預防或治療青光眼之藥物療法
KR20160108121A (ko) 2015-03-06 2016-09-19 코와 가부시키가이샤 수성 조성물
JP2018118905A (ja) * 2015-04-27 2018-08-02 恵 本庄 白内障術後合併症の予防治療剤
CN106310285A (zh) * 2015-06-15 2017-01-11 江苏吉贝尔药业股份有限公司 一种新的盐酸利舒地尔滴眼液及其制备方法
JP6886322B2 (ja) * 2016-03-25 2021-06-16 興和株式会社 眼科用組成物
CN107164328A (zh) * 2017-06-30 2017-09-15 太仓卡斯特姆新材料有限公司 一种高稳定性mcf‑7乳腺癌细胞的复苏方法
CN111479568A (zh) 2017-12-21 2020-07-31 参天制药株式会社 司培前列素与Rho激酶抑制剂的组合药物
CA3207859A1 (en) 2021-01-11 2022-07-14 Incyte Corporation Combination therapy comprising jak pathway inhibitor and rock inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401108D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
JP3719609B2 (ja) * 1995-12-21 2005-11-24 アルコン ラボラトリーズ，インコーポレイテッド 緑内障および眼虚血の治療のための特定のイソキノリンスルホニル化合物の使用
JPH10310576A (ja) * 1997-03-10 1998-11-24 Hiroyoshi Hidaka イソキノリンスルフォンアミド誘導体及びこれを有効成分とする医薬
WO1999054306A1 (fr) * 1997-03-10 1999-10-28 Hiroyoshi Hidaka Derives isoquinolinesulfonamide et medicaments integrant ces derives comme principe actif
PL336586A1 (en) * 1997-04-25 2000-07-03 Pfizer Pyrazoylpyrimidinones inhibiting the cyclic guanosine 3',5'-monophosphate phosphodiesterase of type 5 (cgmp pde5) for treating sexual disorders
FR2777189B1 (fr) 1998-04-09 2001-04-06 Chauvin Lab Sa Composition ophtalmique comprenant un beta-bloquant
JP4212149B2 (ja) * 1998-06-11 2009-01-21 株式会社デ・ウエスタン・セラピテクス研究所 医薬
ES2372572T3 (es) 1998-08-17 2012-01-23 Senju Pharmaceutical Co., Ltd. Agente para profilaxis y tratamiento de glaucoma.
AP2001002103A0 (en) * 1998-10-22 2001-03-31 Neurosearch As Substituted phenyl derivatives, their preparation and use.

Also Published As

Publication number Publication date
NZ555137A (en) 2009-10-30
ZA200704874B (en) 2008-08-27
CY1108651T1 (el) 2014-04-09
EP1818059A4 (en) 2007-12-26
CN101087613B (zh) 2010-08-18
ATE415972T1 (de) 2008-12-15
CN101087613A (zh) 2007-12-12
EP1818059A1 (en) 2007-08-15
TW200628160A (en) 2006-08-16
PT1818059E (pt) 2008-12-31
SI1818059T1 (sl) 2009-04-30
NO20072187L (no) 2007-07-13
JP4099201B2 (ja) 2008-06-11
AU2005320085B2 (en) 2010-07-29
CA2585372A1 (en) 2006-06-29
EA200701134A1 (ru) 2007-10-26
TWI367098B (en) 2012-07-01
WO2006068208A1 (ja) 2006-06-29
MY138811A (en) 2009-07-31
EP1818059B1 (en) 2008-12-03
JPWO2006068208A1 (ja) 2008-06-12
ES2317338T3 (es) 2009-04-16
PL1818059T3 (pl) 2009-05-29
HK1113312A1 (en) 2008-10-03
AU2005320085A1 (en) 2006-06-29
BRPI0519007A2 (pt) 2008-12-23
KR101286813B1 (ko) 2013-07-17
DK1818059T3 (da) 2009-03-16
DE602005011476D1 (de) 2009-01-15
EA011085B1 (ru) 2008-12-30
KR20070090897A (ko) 2007-09-06

Similar Documents

Publication Publication Date Title
MX2007007614A (es) Agente preventivo o terapeutico para glaucoma.
WO2008061043A3 (en) Uveoscleral shunt and methods for implanting same
EP2329842A3 (en) Interleukin-1 inhibitors in the treatment of diseases
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
MY147181A (en) Prostaglandin derivatives.
WO2005069865A3 (en) Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
WO2008140052A1 (ja) ロピニロール又はその塩を有効成分として含有する後眼部疾患の予防又は治療剤
WO2006068829A9 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (lox) and lox-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
RS20070077A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases
WO2009041663A1 (ja) 皮膚疾患の予防及び／または治療剤
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
EP1935417A4 (en) COMPOSITION FOR USE IN PREVENTING A HYPOGLYCEMIC STATE
EP1752158A4 (en) CORNEAL NEURITOGENESIS PROMOTER CONTAINING PACAP AND ITS DERIVATIVE
WO2005101982A3 (en) A stable ophthalmic composition
MX2012007397A (es) Composiciones y metodos para reducir la presion intraocular.
MXPA03005922A (es) Metodo para tratar glaucoma ib.
WO2006102333A3 (en) Ophthalmic use of agents which inhibit connective tissue growth factor binding and signalling via the trka/p75ntr receptor complex
TW200505408A (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
WO2008099804A1 (ja) 糖尿病白内障の治療剤
EP1482922A4 (en) AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
WO2000064425A3 (en) Miotic agents and hypertonic agents containing ophthalmic compositions
TW200806284A (en) Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
WO2009111169A3 (en) Compositions comprising pkc-delta modulators and methods for ocular neuroprotection

Legal Events

Date Code Title Description
FG Grant or registration